NVDA Congressional Stock Trades
NVIDIA Corporation
Last disclosed trade Oct 2
Every disclosed trade in NVDA by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every technology stock Congress trades.
Sample · the intelligence layer
Nancy Pelosi · Bought $NVDA · Jan 14 · $250K–$500K
3 other members traded this name in the same window.
Coldpine’s read
This spouse purchase of 50 NVDA call options, sized at $250,001–$500,000, reflects a leveraged position through 2026 that exceeds the scale of many routine equity disclosures. Three other members made same-direction NVDA trades within 30 days, indicating cluster interest in the name. The 3-day disclosure lag is fast, meaning the market may not have fully absorbed the filing.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $NVDA
Get notified when any member of Congress trades $NVDA. Free, no card, no spam.
The record on $NVDA
Coldpine has parsed 224 disclosed trades in $NVDA by 39 members of Congress, drawn from 134 periodic transaction reports dated Jun 30, 2022 through Oct 2, 2026. That is 209 trades from House members and 15 trades from senators, filed 125 by Democrats and 99 by Republicans.
Of the 223 trades with a known filing lag, 21 were reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 27 days. The longest was 723 days: a $NVDA purchase by Tracey Robert Mann dated Aug 20, 2024, disclosed Aug 13, 2026. How late filing is measured across all of Congress is in the late-filers study.
142 of the 169 trades that list an account holder (84%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Cleo Fields filed the most $NVDA purchases (31), and Daniel Meuser the most sales (18).
Activity peaked in 2025 with 83 trades. The busiest single month was April 2025, when 8 different members disclosed $NVDA trades. In 8 calendar months out of 47 with activity, three or more members bought $NVDA in the same month, the same-direction overlap Coldpine's cluster detector looks for.
Across the 130 purchases Coldpine can price, $NVDA moved +14.80% on average between the trade date and the disclosure date, against +4.56% for the S&P 500 over the same windows. The stock was higher at disclosure than at the trade in 63% of those purchases. That is a record of what already happened, not a forecast. Method: what stocks do before Congress discloses.
Members who trade NVDA
Recent disclosed trades in NVDA
| Date | Member | Type | Amount |
|---|---|---|---|
| Oct 2 | Pete Sessions(TX) | sell | $15K–$50K |
| Oct 1 | Cleo Fields(LA) | buy | $1K–$15K |
| Oct 1 | Cleo Fields(LA) | buy | $1K–$15K |
| Oct 1 | Cleo Fields(LA) | buy | $1K–$15K |
| Sep 23 | Rohit Khanna(CA) | buy | $1K–$15K |
| Sep 4 | Rohit Khanna(CA) | sell | $1K–$15K |
| Aug 31 | Daniel Meuser(PA) | sell | $1K–$15K |
| Aug 18 | John J McGuire(VA) | buy | $1K–$15K |
| Aug 13 | Sheldon Whitehouse(RI) | sell | $1K–$15K |
| Aug 13 | Sheldon Whitehouse(RI) | sell | $15K–$50K |
| Aug 11 | Cory A Booker(NJ) | sell | $15K–$50K |
| Jul 21 | Sam T. Liccardo(CA) | sell | $15K–$50K |
| Jun 30 | Sheldon Whitehouse(RI) | sell | $15K–$50K |
| Jun 26 | Cleo Fields(LA) | buy | $1K–$15K |
| Jun 26 | Cleo Fields(LA) | buy | $1K–$15K |
| Jun 26 | Cleo Fields(LA) | buy | $1K–$15K |
| Jun 25 | Michael Rulli(OH) | buy | $1K–$15K |
| Jun 16 | Matthew Robert Van Epps(TN) | sell | $1K–$15K |
| Jun 5 | Rohit Khanna(CA) | buy | $1K–$15K |
| Jun 5 | Rohit Khanna(CA) | buy | $1K–$15K |
Showing 20 of 224 disclosed trades.
Sign up free for the full history, signal scores, the price-vs-trades chart, and Coldpine's read (the AI narrative on each trade).
Create a free accountFrom Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →